The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Guideline Committee Members(alpha order): Anika Alvanzo, MD, MS, DFASAM, FACP Kurt Kleinschmidt, MD, FASAM Julie A. Kmiec, DO, FASAM George Kolodner, MD, DLFAPA, FASAM Gerald E. Marti, MD, PhD William F. Murphy, DO, MS, DFASAM Carlos F. Tirado, MD, FASAM Corey Waller, MD, MS, DFASAM, FACEP Lewis S. Nelson, MD, FASAM, FACEP, FACMT (Chair) Clinical Champions(alpha order): Stephen Holt, MD, MS, FACP Darius Rastegar, MD, FASAM Richard Saitz, MD, MPH, FACP, DFASAM Michael F. Weaver, MD, DFASAM ASAM Quality Improvement Council∗(alpha order): John Femino, MD, DFASAM Kenneth Freedman, MD, DFASAM (Chair) R. Jeffrey Goldsmith, MD, DLFAPA, DFASAM Barbara Herbert, MD, DFASAM (Past- Chair) Margaret Jarvis, MD, DFASAM Margaret M. Kotz, DO, DFASAM P. Stephen Novack, DO David R. Pating, MD Sandrine Pirard, MD, PhD, MPH, FAPA, FASAM ASAM Staff: Maureen Boyle, PhD, Chief Quality and Science Officer Leah White, MPH, Director of Quality Improvement Taleen Safarian, Manager of Science and Dissemination Institute for Research Education and Training in Addictions (IRETA) Team Members: Dawn Lindsay, PhD, Project Director Jessica Williams, MPH, Assistant Project Director Piper Lincoln, MS, Senior Research Associate Jackie Jones, MS, Research Associate Rachael Vargo, BA, Research Associate Peter F. Luongo, PhD, Executive Director ASAM is honored that this clinical practice guideline has been endorsed by: American College of Preventive Medicine American Osteopathic Academy of Addiction Medicine Federation of State Physician Health Programs National Association of Addiction Treatment Providers National Association of Clinical Nurse Specialists National Commission on Correctional Health Care TABLE OF CONTENTSGLOSSARY OF TERMS Below are terms that are used throughout the guideline. Note that some terms listed below are used to convey a specific meaning for the purposes of this guideline (e.g., “clinicians”). Abstinence: Intentional and consistent restraint from the pathological pursuit of reward and/or relief that involves the use of substances and other behaviors. These behaviors may involve, but are not necessarily limited to substance use, gambling, video gaming, or compulsive sexual behaviors. Use of FDA approved medications for the treatment of substance use disorder is consistent with abstinence. Addiction Specialist Physician: Addiction specialist physicians include addiction medicine physicians and addiction psychiatrists who hold either a subspecialty board certification in addiction medicine by the American Board of Preventative Medicine, a board certification in addiction medicine from the American Board of Addiction Medicine, a subspecialty board certification in addiction psychiatry from the American Board of Psychiatry and Neurology, a subspecialty board certification in addiction medicine from the American Osteopathic Association, or certification in addiction medicine from the American Society of Addiction Medicine. Adjunct therapy (see also monotherapy): A pharmaceutical drug used together with a primary pharmaceutical drug whose purpose is to assist the primary treatment.1 Alcohol Hallucinosis/Alcohol-induced Psychotic Disorder: See Special Terms on page 18. ASAM Criteria dimensions:The ASAM Criteria use six dimensions to define a holistic biopsychosocial assessment of an individual to be used for service and treatment planning including acute intoxication or withdrawal potential; biomedical conditions and complications; emotional, behavioral, or cognitive conditions or complications; readiness for change; continued use or continued problem potential; and recovery/living environment. CIWA-Ar: The Clinical Institute Withdrawal Assessment of Alcohol Scale, Revised, is a reliable, valid, and reproducible severity of alcohol withdrawal in communicative patients once a diagnosis has been made.2 Complicated alcohol withdrawal: See Special Terms on page 16. Clinicians (Healthcare providers): Used throughout the guideline, this term is intentionally broad. It encompasses anyone who participates in providing care to patients with substance use disorders, including staff at specialty addiction treatment centers or other healthcare settings that provide substance use disorder treatment.3 Fixed-dosing: See Special Terms on page 16. Front loading: See Special Terms on page 16. GABAergic agents: Drugs that affect the neurotransmitter GABA or its receptors. These include agonists, antagonists, modulators, reuptake inhibitors and enzymes. Examples include benzodiazepines, phenobarbital, and carbamazepine. Inpatient Withdrawal Management: See Special Terms on page 16. Kindling: The relationship between repeated episodes of alcohol withdrawal which become progressively more severe is referred to as the kindling effect or process.4 The effect is theorized to be the result of increased neuronal excitability and sensitivity with repeated episodes of withdrawal and has been demonstrated to result in increased craving for alcohol and decreas
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SAUNDERS, J. B., AASLAND, O. G., BABOR, T. F., DE LA FUENTE, J. R., & GRANT, M. (1993) · Addiction · doi:10.1111/j.1360-0443.1993.tb02093.x · Cited by 13,597
Sessler, C. N., Gosnell, M. S., Grap, M. J., Brophy, G. M., O'Neal, P. V., Keane, K. A., Tesoro, E. P., & Elswick, R. K. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2107138 · Cited by 3,695
Ely, E. W., Inouye, S. K., Bernard, G. R., Gordon, S., Francis, J., May, L., Truman, B., Speroff, T., Gautam, S., Margolin, R., et al. (2001) · JAMA · doi:10.1001/jama.286.21.2703 · Cited by 3,210
SULLIVAN, J. T., SYKORA, K., SCHNEIDERMAN, J., NARANJO, C. A., & SELLERS, E. M. (1989) · British Journal of Addiction · doi:10.1111/j.1360-0443.1989.tb00737.x · Cited by 1,988
Group, W. A. W. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00185.x · Cited by 1,982
Validation of the alcohol smoking and substance involvement screening test (ASSIST)
Humeniuk, R., Ali, R., Babor, T. F., Farrell, M., Formigoni, M. L., Jittiwutikarn, J., De Lacerda, R. B., Ling, W., Marsden, J., Monteiro, M., et al. (2008) · Addiction · doi:10.1111/j.1360-0443.2007.02114.x · Cited by 1,144
Delirium in Older Persons: Advances in Diagnosis and Treatment
Oh, E. S., Fong, T. G., Hshieh, T. T., & Inouye, S. K. (2017) · JAMA · doi:10.1001/jama.2017.12067 · Cited by 926
Management of Drug and Alcohol Withdrawal
Kosten, T. R., & O'Connor, P. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020617 · Cited by 563
Mayo-Smith, M. F. (1997) · JAMA · doi:10.1001/jama.278.2.144 · Cited by 434
Gabapentin misuse, abuse and diversion: A systematic review
Smith, R. V., Havens, J. R., & Walsh, S. L. (2016) · Addiction · doi:10.1111/add.13324 · Cited by 378
Cited by
Canadian Guideline for the Clinical Management of High-Risk Drinking and Alcohol Use Disorder
Wood, E., Bright, J., Hsu, K., Goel, N., Ross, J. W. G., Hanson, A., Teed, R., Poulin, G., Denning, B., Corace, K., et al. (2023) · Canadian Medical Association Journal · doi:10.1503/cmaj.230715 · Cited by 74
Metadata
- Venue
- Journal of Addiction Medicine
- Published
- 2020-05
- Volume
- 14
- Issue
- 3S
- Pages
- 1-72
- ISSN
- 1932-0620 (ISSN-L)
- 1935-3227
- OpenAlex
- W3033273022
- Cited by
- 185
- References
- 17
- FWCI
- 6.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management. https://app.cochat.ai/papers/10.1097/adm.0000000000000668
- The paper
- The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management. (2020). Journal of Addiction Medicine. https://doi.org/10.1097/adm.0000000000000668
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.